| (+)-catechin | decreases activity | ISO | RGD:1354178 | 6480464 | Catechin results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1354178 | 6480464 | epigallocatechin gallate binds to and results in decreased activity of DNMT1 protein | CTD | PMID:14633667 |
| (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RGD:1354178 | 6480464 | Magnesium promotes the reaction [epigallocatechin gallate results in decreased activity of DNMT1 protein] | CTD | PMID:16037419 |
| (-)-epigallocatechin 3-gallate | decreases activity | ISO | RGD:1354178 | 6480464 | epigallocatechin gallate results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| (R)-rosmarinic acid | decreases expression | ISO | RGD:1354178 | 6480464 | rosmarinic acid results in decreased expression of DNMT1 protein | CTD | PMID:21078381 |
| 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:1552151 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT1 mRNA | CTD | PMID:17942748 |
| 17alpha-ethynylestradiol | increases expression | ISO | RGD:1552151 | 6480464 | Ethinyl Estradiol results in increased expression of DNMT1 mRNA | CTD | PMID:17942748 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1354178 | 6480464 | [sodium arsenite co-treated with Estradiol] results in decreased expression of DNMT1 mRNA | CTD | PMID:22952798 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1354178 | 6480464 | [Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [DNMT1 protein binds to BRCA1 promoter]; more ... | CTD | PMID:20631324 |
| 17beta-estradiol | decreases expression | ISO | RGD:1354178 | 6480464 | Estradiol results in decreased expression of DNMT1 mRNA | CTD | PMID:22952798 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1552151 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of DNMT1 mRNA | CTD | PMID:17942748 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1354178 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] | CTD | PMID:22197621 |
| 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:1354178 | 6480464 | Tetrachlorodibenzodioxin inhibits the reaction [DNMT1 protein binds to BRCA1 promoter]; more ... | CTD | PMID:20631324 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1552151 | 6480464 | Tetrachlorodibenzodioxin affects the expression of DNMT1 mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1552151 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of DNMT1 mRNA | CTD | PMID:15667827 |
| 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | RGD:1552151 | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of DNMT1 mRNA | CTD | PMID:16611356 |
| 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2,6-dinitrotoluene affects the expression of DNMT1 mRNA | CTD | PMID:21346803 |
| 5-aza-2'-deoxycytidine | increases degradation | ISO | RGD:1354178 | 6480464 | decitabine results in increased degradation of DNMT1 protein | CTD | PMID:19417133 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:17571247 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 mRNA | CTD | PMID:16613325 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:17571247 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:17571247 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 mRNA | CTD | PMID:17621267 more ... |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1354178 | 6480464 | decitabine inhibits the reaction [Cadmium Chloride results in increased expression of DNMT1 mRNA]; more ... | CTD | PMID:22112500 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:17616700 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:17991895 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1552151 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:19222872 PMID:19679824 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:17616700 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:19117987 more ... |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 mRNA | CTD | PMID:18676679 PMID:17621267 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:19732952 more ... |
| 5-aza-2'-deoxycytidine | affects response to substance | ISO | RGD:1552151 | 6480464 | DNMT1 affects the susceptibility to decitabine | CTD | PMID:14581508 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1354178 | 6480464 | IL6 protein inhibits the reaction [decitabine results in decreased expression of DNMT1 mRNA] | CTD | PMID:17621267 |
| 5-aza-2'-deoxycytidine | affects response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein affects the susceptibility to decitabine | CTD | PMID:17991895 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1552151 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:19679824 PMID:19222872 |
| 5-aza-2'-deoxycytidine | increases expression | ISO | RGD:1354178 | 6480464 | decitabine results in increased expression of DNMT1 mRNA | CTD | PMID:19117987 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1354178 | 6480464 | DNMT1 protein affects the reaction [decitabine results in increased expression of H2AFX protein] | CTD | PMID:17991895 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 mRNA | CTD | PMID:17621267 PMID:18676679 |
| 5-aza-2'-deoxycytidine | decreases expression | ISO | RGD:1354178 | 6480464 | decitabine results in decreased expression of DNMT1 protein | CTD | PMID:18676679 more ... |
| 5-azacytidine | decreases expression | ISO | RGD:1354178 | 6480464 | Azacitidine results in decreased expression of DNMT1 mRNA | CTD | PMID:15547111 |
| 5-azacytidine | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with Azacitidine] results in decreased expression of DNMT1 protein | CTD | PMID:19723570 |
| 5-azacytidine | decreases expression | EXP | | 6480464 | Azacitidine results in decreased expression of DNMT1 protein | CTD | PMID:19723570 PMID:21224363 |
| 5-azacytidine | multiple interactions | EXP | | 6480464 | [Azacitidine co-treated with N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide] results in decreased expression of DNMT1 protein; more ... | CTD | PMID:21224363 |
| 5-azacytidine | decreases expression | EXP | | 6480464 | Azacitidine results in decreased expression of DNMT1 protein | CTD | PMID:21224363 |
| 5-azacytidine | multiple interactions | ISO | RGD:1354178 | 6480464 | pifithrin inhibits the reaction [Azacitidine results in decreased expression of DNMT1 mRNA]; more ... | CTD | PMID:15547111 |
| 5-azacytidine | multiple interactions | ISO | RGD:1354178 | 6480464 | [SLC28A1 protein results in increased uptake of Azacitidine] which results in decreased expression of DNMT1 protein | CTD | PMID:19139132 |
| 7,12-dimethyltetraphene | increases expression | EXP | | 6480464 | 9,10-Dimethyl-1,2-benzanthracene results in increased expression of DNMT1 mRNA | CTD | PMID:12097258 |
| 8-hydroxy-2'-deoxyguanosine | affects abundance | ISO | RGD:1354178 | 6480464 | DNMT1 gene SNP affects the abundance of 8-oxo-7-hydrodeoxyguanosine | CTD | PMID:19896490 |
| acetic acid | decreases expression | ISO | RGD:1354178 | 6480464 | Acetic Acid results in decreased expression of DNMT1 protein | CTD | PMID:17065238 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1354178 | 6480464 | Tretinoin results in decreased expression of DNMT1 mRNA | CTD | PMID:17273765 |
| amitriptyline | decreases activity | EXP | | 6480464 | Amitriptyline results in decreased activity of DNMT1 protein | CTD | PMID:19924110 |
| arsenic atom | decreases expression | EXP | | 6480464 | Arsenic results in decreased expression of DNMT1 protein | CTD | PMID:9380733 |
| arsenic atom | increases expression | EXP | | 6480464 | Arsenic results in increased expression of DNMT1 mRNA | CTD | PMID:9380733 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1552151 | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of DNMT1 mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1354178 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Benzo(a)pyrene results in increased degradation of DNMT1 protein] | CTD | PMID:21150308 |
| benzo[a]pyrene | increases degradation | ISO | RGD:1354178 | 6480464 | Benzo(a)pyrene results in increased degradation of DNMT1 protein | CTD | PMID:21150308 |
| benzo[a]pyrene | increases expression | ISO | RGD:1552151 | 6480464 | Benzo(a)pyrene results in increased expression of DNMT1 mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1552151 | 6480464 | Benzo(a)pyrene results in decreased expression of DNMT1 mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1552151 | 6480464 | Benzo(a)pyrene inhibits the reaction [[DNMT1 protein binds to HDAC1 protein] which binds to CYP1A1 promoter] | CTD | PMID:17682057 |
| bisphenol A | decreases expression | ISO | RGD:1552151 | 6480464 | bisphenol A results in decreased expression of DNMT1 mRNA | CTD | PMID:21980460 PMID:22131059 |
| bisphenol A | decreases expression | ISO | RGD:1552151 | 6480464 | bisphenol A results in decreased expression of DNMT1 mRNA | CTD | PMID:22131059 PMID:21980460 |
| bisphenol A | multiple interactions | ISO | RGD:1552151 | 6480464 | fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT1 mRNA] | CTD | PMID:22131059 |
| bleomycin A2 | affects response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein affects the susceptibility to Bleomycin | CTD | PMID:17991895 |
| buta-1,3-diene | decreases expression | ISO | RGD:1552151 | 6480464 | 1,3-butadiene results in decreased expression of DNMT1 protein | CTD | PMID:21147608 |
| cadmium atom | affects response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 gene SNP affects the susceptibility to Cadmium | CTD | PMID:22382075 |
| cadmium dichloride | multiple interactions | ISO | RGD:1354178 | 6480464 | [Cadmium Chloride results in increased activity of [DNMT1 protein co-treated with DNMT3A protein]] which results in increased methylation of ERCC1 promoter; more ... | CTD | PMID:22112500 |
| cadmium dichloride | increases expression | ISO | RGD:1354178 | 6480464 | Cadmium Chloride results in increased expression of DNMT1 mRNA | CTD | PMID:22112500 |
| calcitriol | decreases expression | ISO | RGD:1354178 | 6480464 | Calcitriol results in decreased expression of DNMT1 mRNA | CTD | PMID:21592394 |
| calcitriol | multiple interactions | ISO | RGD:1354178 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of DNMT1 mRNA | CTD | PMID:21592394 |
| choline | affects activity | ISO | RGD:1552151 | 6480464 | Choline affects the activity of DNMT1 protein | CTD | PMID:16855792 |
| choline | multiple interactions | ISO | RGD:1552151 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DNMT1 mRNA; more ... | CTD | PMID:20978746 |
| chromium atom | multiple interactions | ISO | RGD:1552151 | 6480464 | Chromium promotes the reaction [[DNMT1 protein binds to HDAC1 protein] which binds to CYP1A1 promoter] | CTD | PMID:17682057 |
| cisplatin | decreases response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:21458988 PMID:18314485 |
| cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of DNMT1 protein | CTD | PMID:19723570 |
| cisplatin | multiple interactions | EXP | | 6480464 | [Cisplatin co-treated with Azacitidine] results in decreased expression of DNMT1 protein | CTD | PMID:19723570 |
| cisplatin | decreases response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:18314485 PMID:21458988 |
| cisplatin | decreases response to substance | EXP | | 6480464 | DNMT1 protein results in decreased susceptibility to Cisplatin | CTD | PMID:18314485 |
| cobalt dichloride | decreases expression | ISO | RGD:1354178 | 6480464 | cobaltous chloride results in decreased expression of DNMT1 mRNA | CTD | PMID:19320972 |
| copper atom | multiple interactions | ISO | RGD:1354178 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DNMT1 mRNA | CTD | PMID:20971185 |
| copper(0) | multiple interactions | ISO | RGD:1354178 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of DNMT1 mRNA | CTD | PMID:20971185 |
| coumestrol | multiple interactions | ISO | RGD:1354178 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of DNMT1 mRNA; more ... | CTD | PMID:19167446 |
| coumestrol | increases expression | ISO | RGD:1354178 | 6480464 | Coumestrol results in increased expression of DNMT1 mRNA | CTD | PMID:19167446 |
| cyclophosphamide | multiple interactions | ISO | RGD:1354178 | 6480464 | Cyclophosphamide promotes the reaction [KDM1A protein results in decreased methylation of and results in decreased degradation of DNMT1 protein] | CTD | PMID:22007908 |
| cyclophosphamide | increases expression | ISO | RGD:1354178 | 6480464 | Cyclophosphamide results in increased expression of DNMT1 protein | CTD | PMID:22007908 |
| cyclophosphamide | decreases methylation | ISO | RGD:1354178 | 6480464 | Cyclophosphamide results in decreased methylation of DNMT1 protein | CTD | PMID:22007908 |
| cyclosporin A | increases expression | ISO | RGD:1552151 | 6480464 | Cyclosporine results in increased expression of DNMT1 mRNA | CTD | PMID:19770486 |
| DDT | decreases expression | EXP | | 6480464 | DDT results in decreased expression of DNMT1 mRNA | CTD | PMID:19797855 |
| diarsenic trioxide | decreases expression | ISO | RGD:1552151 | 6480464 | arsenic trioxide results in decreased expression of DNMT1 protein | CTD | PMID:19679824 |
| diarsenic trioxide | decreases expression | ISO | RGD:1354178 | 6480464 | arsenic trioxide results in decreased expression of DNMT1 mRNA | CTD | PMID:16613325 more ... |
| diarsenic trioxide | decreases expression | ISO | RGD:1354178 | 6480464 | arsenic trioxide results in decreased expression of DNMT1 protein | CTD | PMID:22558281 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1354178 | 6480464 | arsenic trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]; more ... | CTD | PMID:22558281 |
| diarsenic trioxide | decreases expression | ISO | RGD:1354178 | 6480464 | arsenic trioxide results in decreased expression of DNMT1 mRNA | CTD | PMID:17490527 PMID:20596618 |
| diarsenic trioxide | decreases activity | ISO | RGD:1354178 | 6480464 | arsenic trioxide results in decreased activity of DNMT1 protein | CTD | PMID:20596618 |
| diarsenic trioxide | decreases expression | ISO | RGD:1354178 | 6480464 | arsenic trioxide results in decreased expression of DNMT1 mRNA | CTD | PMID:20596618 PMID:17490527 |
| dibutyl phthalate | decreases expression | ISO | RGD:1552151 | 6480464 | Dibutyl Phthalate results in decreased expression of DNMT1 mRNA | CTD | PMID:21266533 |
| diethylstilbestrol | increases expression | ISO | RGD:1552151 | 6480464 | Diethylstilbestrol results in increased expression of DNMT1 mRNA | CTD | PMID:16714842 |
| dimethyl sulfate | decreases expression | ISO | RGD:1354178 | 6480464 | dimethyl sulfate results in decreased expression of DNMT1 protein | CTD | PMID:11912126 |
| dimethyl sulfoxide | decreases expression | ISO | RGD:1354178 | 6480464 | Dimethyl Sulfoxide results in decreased expression of DNMT1 protein | CTD | PMID:17065238 |
| dioxygen | increases expression | ISO | RGD:1354178 | 6480464 | Oxygen deficiency results in increased expression of DNMT1 protein | CTD | PMID:18314485 |
| disodium selenite | decreases expression | ISO | RGD:1354178 | 6480464 | Sodium Selenite results in decreased expression of DNMT1 protein; more ... | CTD | PMID:18676679 |
| doxorubicin | affects response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein affects the susceptibility to Doxorubicin | CTD | PMID:17991895 |
| doxorubicin | multiple interactions | ISO | RGD:1354178 | 6480464 | Doxorubicin promotes the reaction [DNMT1 protein binds to CHEK1 protein] | CTD | PMID:17991895 |
| doxorubicin | multiple interactions | ISO | RGD:1354178 | 6480464 | Doxorubicin promotes the reaction [DNMT1 protein binds to BIRC5 promoter] | CTD | PMID:17124180 |
| doxorubicin | multiple interactions | ISO | RGD:1354178 | 6480464 | Doxorubicin inhibits the reaction [DNMT1 binds to RELN promoter]; more ... | CTD | PMID:17065238 |
| elemental selenium | affects activity | EXP | | 6480464 | Selenium affects the activity of DNMT1 protein | CTD | PMID:16632891 |
| etoposide | decreases response to substance | EXP | | 6480464 | DNMT1 protein results in decreased susceptibility to Etoposide | CTD | PMID:18314485 |
| etoposide | decreases response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein results in decreased susceptibility to Etoposide | CTD | PMID:18314485 |
| fisetin | multiple interactions | ISO | RGD:1354178 | 6480464 | [fisetin co-treated with COMT protein] results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| folic acid | affects expression | ISO | RGD:1354178 | 6480464 | Folic Acid affects the expression of DNMT1 mRNA | CTD | PMID:17311948 |
| folic acid | multiple interactions | ISO | RGD:1552151 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of DNMT1 mRNA; more ... | CTD | PMID:20978746 |
| folic acid | affects activity | ISO | RGD:1552151 | 6480464 | Folic Acid affects the activity of DNMT1 protein | CTD | PMID:16855792 |
| formaldehyde | increases expression | ISO | RGD:1354178 | 6480464 | Formaldehyde results in increased expression of DNMT1 mRNA; more ... | CTD | PMID:21745553 |
| fulvestrant | multiple interactions | ISO | RGD:1354178 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of DNMT1 mRNA | CTD | PMID:19016759 |
| fulvestrant | multiple interactions | ISO | RGD:1552151 | 6480464 | fulvestrant inhibits the reaction [bisphenol A results in decreased expression of DNMT1 mRNA] | CTD | PMID:22131059 |
| fulvestrant | decreases expression | ISO | RGD:1354178 | 6480464 | fulvestrant results in decreased expression of DNMT1 mRNA | CTD | PMID:19016759 |
| genistein | decreases expression | ISO | RGD:1354178 | 6480464 | Genistein results in decreased expression of DNMT1 mRNA | CTD | PMID:16705744 |
| genistein | decreases expression | ISO | RGD:1354178 | 6480464 | Genistein results in decreased expression of DNMT1 protein | CTD | PMID:19221000 |
| hydrogen peroxide | increases expression | ISO | RGD:1354178 | 6480464 | Hydrogen Peroxide results in increased expression of DNMT1 protein | CTD | PMID:18314485 |
| hydrogen peroxide | decreases response to substance | EXP | | 6480464 | DNMT1 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:18314485 |
| hydrogen peroxide | decreases response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein results in decreased susceptibility to Hydrogen Peroxide | CTD | PMID:18314485 |
| hydroquinone | decreases expression | ISO | RGD:1354178 | 6480464 | hydroquinone results in decreased expression of DNMT1 mRNA | CTD | PMID:22245671 |
| hydroxyurea | affects response to substance | ISO | RGD:1354178 | 6480464 | DNMT1 protein affects the susceptibility to Hydroxyurea | CTD | PMID:17991895 |
| hypochlorous acid | decreases expression | ISO | RGD:1552151 | 6480464 | Hypochlorous Acid results in decreased expression of DNMT1 mRNA | CTD | PMID:19376150 |
| L-methionine | multiple interactions | ISO | RGD:1552151 | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency co-treated with sodium arsenite] results in decreased expression of DNMT1 mRNA; more ... | CTD | PMID:20978746 |
| lead diacetate | decreases expression | EXP | | 6480464 | lead acetate results in decreased expression of DNMT1 mRNA | CTD | PMID:21117136 PMID:22764079 |
| leptomycin B | multiple interactions | ISO | RGD:1354178 | 6480464 | [leptomycin B co-treated with TP53 gene mutant form] results in decreased expression of DNMT1 mRNA | CTD | PMID:20803015 |
| leptomycin B | decreases expression | ISO | RGD:1354178 | 6480464 | leptomycin B results in decreased expression of DNMT1 mRNA | CTD | PMID:20803015 |
| magnesium atom | decreases activity | ISO | RGD:1354178 | 6480464 | Magnesium results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| magnesium atom | multiple interactions | ISO | RGD:1354178 | 6480464 | Magnesium promotes the reaction [epigallocatechin gallate results in decreased activity of DNMT1 protein] | CTD | PMID:16037419 |
| methyl methanesulfonate | decreases expression | ISO | RGD:1354178 | 6480464 | Methyl Methanesulfonate results in decreased expression of DNMT1 protein | CTD | PMID:11912126 |
| methyl methanesulfonate | increases degradation | ISO | RGD:1354178 | 6480464 | Methyl Methanesulfonate results in increased degradation of DNMT1 protein | CTD | PMID:11912126 |
| methylarsonic acid | decreases expression | EXP | | 6480464 | monomethylarsonic acid results in decreased expression of DNMT1 mRNA | CTD | PMID:17481689 |
| methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of DNMT1 mRNA | CTD | PMID:19636072 |
| mono(2-ethylhexyl) phthalate | increases expression | ISO | RGD:1552151 | 6480464 | mono-(2-ethylhexyl)phthalate results in increased expression of DNMT1 mRNA | CTD | PMID:22401849 |
| myricetin | multiple interactions | ISO | RGD:1354178 | 6480464 | [myricetin co-treated with COMT protein] results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| myricetin | decreases activity | ISO | RGD:1354178 | 6480464 | myricetin results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| N-ethyl-N-nitrosourea | increases expression | ISO | RGD:1552151 | 6480464 | Ethylnitrosourea results in increased expression of DNMT1 | CTD | PMID:21154115 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1552151 | 6480464 | AHR protein inhibits the reaction [Diethylnitrosamine results in decreased expression of DNMT1 mRNA] | CTD | PMID:19996281 |
| N-nitrosodiethylamine | increases expression | ISO | RGD:1552151 | 6480464 | Diethylnitrosamine results in increased expression of DNMT1 mRNA | CTD | PMID:17854601 |
| N-nitrosodiethylamine | multiple interactions | ISO | RGD:1552151 | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of DNMT1 mRNA] | CTD | PMID:17854601 |
| N-nitrosodiethylamine | decreases expression | ISO | RGD:1552151 | 6480464 | Diethylnitrosamine results in decreased expression of DNMT1 mRNA | CTD | PMID:19996281 |
| paracetamol | affects expression | ISO | RGD:1552151 | 6480464 | Acetaminophen affects the expression of DNMT1 mRNA | CTD | PMID:17562736 |
| paracetamol | increases expression | ISO | RGD:1354178 | 6480464 | Acetaminophen results in increased expression of DNMT1 mRNA | CTD | PMID:22230336 |
| phenobarbital | affects expression | ISO | RGD:1552151 | 6480464 | Phenobarbital affects the expression of DNMT1 mRNA | CTD | PMID:19482888 |
| piperonyl butoxide | increases expression | EXP | | 6480464 | Piperonyl Butoxide results in increased expression of DNMT1 mRNA | CTD | PMID:22484513 |
| pirinixic acid | decreases expression | ISO | RGD:1552151 | 6480464 | pirinixic acid results in decreased expression of DNMT1 mRNA | CTD | PMID:17426115 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of DNMT1 protein | CTD | PMID:18639561 |
| piroxicam | increases expression | ISO | RGD:1354178 | 6480464 | Piroxicam results in increased expression of DNMT1 mRNA | CTD | PMID:21858171 |
| quercetin | multiple interactions | ISO | RGD:1354178 | 6480464 | [Quercetin co-treated with COMT protein] results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| quercetin | increases expression | ISO | RGD:1354178 | 6480464 | Quercetin results in increased expression of DNMT1 mRNA | CTD | PMID:21632981 |
| quinoline | multiple interactions | ISO | RGD:1354178 | 6480464 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [quinoline analog results in increased degradation of DNMT1 protein] | CTD | PMID:19417133 |
| quinoline | increases degradation | ISO | RGD:1354178 | 6480464 | quinoline analog results in increased degradation of DNMT1 protein | CTD | PMID:19417133 |
| quinoline | decreases activity | ISO | RGD:1552151 | 6480464 | quinoline analog results in decreased activity of DNMT1 protein | CTD | PMID:19417133 |
| resveratrol | multiple interactions | ISO | RGD:1354178 | 6480464 | resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] | CTD | PMID:20631324 |
| resveratrol | multiple interactions | ISO | RGD:1354178 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] | CTD | PMID:22197621 |
| resveratrol | multiple interactions | ISO | RGD:1354178 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of DNMT1 mRNA | CTD | PMID:19167446 |
| rosmarinic acid | decreases expression | ISO | RGD:1354178 | 6480464 | rosmarinic acid results in decreased expression of DNMT1 protein | CTD | PMID:21078381 |
| S-adenosyl-L-homocysteine | decreases activity | ISO | RGD:1354178 | 6480464 | S-Adenosylhomocysteine results in decreased activity of DNMT1 protein | CTD | PMID:16037419 |
| S-adenosyl-L-homocysteine | multiple interactions | ISO | RGD:1552151 | 6480464 | S-Adenosylhomocysteine inhibits the reaction [DNMT1 protein binds to OGG1 promoter] | CTD | PMID:22064374 |
| S-adenosyl-L-homocysteine | decreases activity | ISO | RGD:1552151 | 6480464 | S-Adenosylhomocysteine results in decreased activity of DNMT1 protein | CTD | PMID:22064374 |
| S-adenosyl-L-methionine | multiple interactions | ISO | RGD:1354178 | 6480464 | S-Adenosylmethionine inhibits the reaction [arsenic trioxide inhibits the reaction [DNMT1 protein binds to ESR1 promoter]]; more ... | CTD | PMID:22558281 |
| selenium atom | affects activity | EXP | | 6480464 | Selenium affects the activity of DNMT1 protein | CTD | PMID:16632891 |
| silicon dioxide | multiple interactions | ISO | RGD:1354178 | 6480464 | DNMT1 protein promotes the reaction [Silicon Dioxide results in increased methylation of PARP1 promoter] | CTD | PMID:22265868 |
| sirolimus | multiple interactions | ISO | RGD:1354178 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of DNMT1 mRNA | CTD | PMID:19016759 |
| testosterone | multiple interactions | ISO | RGD:1354178 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of DNMT1 mRNA | CTD | PMID:21592394 |
| testosterone | multiple interactions | EXP | | 6480464 | [Testosterone co-treated with vinclozolin] results in increased expression of DNMT1 mRNA; more ... | CTD | PMID:20056826 |
| testosterone | decreases expression | ISO | RGD:1354178 | 6480464 | Testosterone results in decreased expression of DNMT1 mRNA | CTD | PMID:21592394 |
| tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of DNMT1 mRNA; more ... | CTD | PMID:22841775 |
| trans-resveratrol | multiple interactions | ISO | RGD:1354178 | 6480464 | resveratrol inhibits the reaction [[Estradiol co-treated with Tetrachlorodibenzodioxin] promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] | CTD | PMID:20631324 |
| trans-resveratrol | multiple interactions | ISO | RGD:1354178 | 6480464 | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin promotes the reaction [DNMT1 protein binds to BRCA1 promoter]] | CTD | PMID:22197621 |
| trans-resveratrol | multiple interactions | ISO | RGD:1354178 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of DNMT1 mRNA | CTD | PMID:19167446 |
| trichloroethene | increases expression | ISO | RGD:1552151 | 6480464 | Trichloroethylene results in increased expression of DNMT1 mRNA | CTD | PMID:22407948 |
| trimellitic anhydride | increases expression | ISO | RGD:1552151 | 6480464 | trimellitic anhydride results in increased expression of DNMT1 mRNA | CTD | PMID:19042947 |
| trimethylarsine oxide | decreases expression | EXP | | 6480464 | trimethylarsine oxide results in decreased expression of DNMT1 mRNA | CTD | PMID:17481689 |
| troglitazone | decreases expression | ISO | RGD:1354178 | 6480464 | troglitazone results in decreased expression of DNMT1 mRNA | CTD | PMID:19140230 |
| vancomycin | decreases expression | ISO | RGD:1552151 | 6480464 | Vancomycin results in decreased expression of DNMT1 mRNA | CTD | PMID:18930951 |